This meta-analysis suggests that the TNF-α rs1800629 polymorphism may be associated with an increased risk of inhibitor development in patients with hemophilia. These findings highlight the potential role of inflammatory genetic variants in modulating the immune response to replacement therapy. Further large-scale, multi-ethnic studies are needed to confirm these results and better understand the underlying mechanisms.
Bezerra et al. (2026) studied this question.